Company / R&D Expense
AIM ImmunoTech Inc. R&D Expense History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest R&D Expense
$3.9M
FY2025
5-year range
$3.9M / $10.9M
FY2021-FY2025
Trend
-64.1%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
R&D Expense has fluctuated over the past 10 years, ranging from $4M in FY2025 to $11M in FY2024.
Based on SEC 10-K filings.
$4M in FY2025 with a 5-year CAGR of -7.3%.
Declined from $7M to $4M over the past 2 years.
R&D Expense over time
Growth rates
- 3-Year CAGR
- -20.0%
- 5-Year CAGR
- -7.3%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of -7.3%, indicating a declining trend.
- In FY2025, r&d expense decreased 64.1% year-over-year.
- Peak r&d expense was recorded in FY2024.
Company context
Key Data Points
- Altman Z-Score -71.45 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | R&D ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.9M | -64.1% |
| FY2024 | $10.9M | +56.5% |
| FY2023 | $7.0M | -8.9% |
| FY2022 | $7.7M | +34.1% |
| FY2021 | $5.7M | +0.0% |
| FY2020 | $5.7M | +23.0% |
| FY2019 | $4.7M | -2.7% |
| FY2018 | $4.8M | -40.6% |
| FY2017 | $8.0M | +57.4% |
| FY2016 | $5.1M | -36.5% |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026